MRI-PDFF

OTHER2 trials

Sponsors

Corcept Therapeutics, University Hospital, Toulouse

Conditions

Non Alcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis (NASH)

Unknown Phase

A Sub Study of the Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)

CompletedNCT05320146

Corcept TherapeuticsNonalcoholic Steatohepatitis (NASH)

Start: 2022-03-04End: 2023-07-18Updated: 2024-08-19

Impact of Artificial Intelligence Algorithm-driven Versus Standard Lifestyle Intervention in Non-Alcoholic Fatty Liver Disease - A Multicenter, Randomized, Open-label, Controlled Trial

Not yet recruitingNCT07497750

University Hospital, ToulouseNon Alcoholic Fatty Liver Disease

Start: 2026-06-01End: 2030-12-31Target: 216Updated: 2026-03-27